Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Neuro-oncology; Central nervous system metastases; Neurological symptoms;
مقالات ISI سرطان متاستاتیک سینه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Efficacy; Endocrine treatment; Fulvestrant; Obesity; BMI;
Keywords: سرطان متاستاتیک سینه; Oral etoposide; Metastatic breast cancer; Heavily pretreated; Low dose chemotherapy;
Keywords: سرطان متاستاتیک سینه; 5FU; fluorouracil 5%; CMOBC; cutaneous metastases of breast cancer; MBC; metastatic breast cancer; TLR7; toll-like receptor 7; antitumor immunity; breast cancer; cryotherapy; cutaneous metastases; fluorouracil; imiquimod; in situ vaccination; skin-direct
Keywords: سرطان متاستاتیک سینه; metastatic breast cancer; MBC; lobaplatin and gemcitabine; GL; lobaplatin and vinorelbine; NL; cisplatin and gemcitabine; GP; cisplatin and vinorelbine; NP; progression-free survival; PFS; overall survival; OS; response rate; RR; platinum-based compounds;
Keywords: سرطان متاستاتیک سینه; Global analysis; Advanced breast cancer; Metastatic breast cancer;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Targeted therapy; Endocrine therapy; Hormone-receptor positive; Adverse events;
Keywords: سرطان متاستاتیک سینه; Competing risks; Conditional probability; Cumulative incidence; Regression model; Metastatic breast cancer;
Keywords: سرطان متاستاتیک سینه; Biomarkers; CDK inhibitors; Complete response; Metastatic breast cancer; Palbociclib;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Sub-Saharan Africa; Prognostic factors; Therapy;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; electronic diary; pain intensity; analgesic use; ambulatory assessment;
Keywords: سرطان متاستاتیک سینه; MVD; microvessel density; BC; breast cancer; mBC; metastatic breast cancer; SREs; skeletal-related events; CD34Â +Â EC; CD34 positive endothelial cell; TNM; tumor node metastasis; H&E; hematoxylin and eosin; PBS; phosphate buffered saline; BSA; bull serum
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Breast cancer; National cancer control plan; Policy; Advocacy; Implementation;
Keywords: سرطان متاستاتیک سینه; Endocrine therapy; Estrogen; Human epidermal growth factor; Metastatic breast cancer; Progesterone;
Keywords: سرطان متاستاتیک سینه; RCC; renal cell carcinoma; CT; computed tomography; US; ultrasonography; FNA; fine-needle aspiration; CNB; core-needle biopsy; MRI; magnetic resonance imaging; ALND; axillary lymph node dissection; Metastatic breast cancer; Renal cell carcinoma; Cryoablat
Keywords: سرطان متاستاتیک سینه; Central nervous system metastasis; Leptomeningeal disease; Metastatic breast cancer; Prognosis; Survival in patients with leptomeningeal metastases;
Keywords: سرطان متاستاتیک سینه; Eribulin; Metastatic breast cancer; First-line; Microtubule; Dose-intensity; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; DCR; disease control rate; DOR; duration of response; ECOG PS; Eas
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Circulating tumor cells; Predictive value; Nanotechnology;
Keywords: سرطان متاستاتیک سینه; Breast cancer; Imaging; Overuse; Utilization; Surveillance; Staging; ASCO; American Society of Clinical Oncology; NCCN; National Comprehensive Cancer Network; ESMO; European Society of Medical Oncology; ESO; European School for Oncology; MBC; metastatic b
Keywords: سرطان متاستاتیک سینه; Metronomic chemotherapy; Metastatic breast cancer; Oral vinorelbine;
Keywords: سرطان متاستاتیک سینه; Theranostics; SPION; Metastatic breast cancer; Stem cell; Docetaxel; Silibinin;
Keywords: سرطان متاستاتیک سینه; Whole-body magnetic resonance imaging; Systemic anti-cancer treatment response assessment; Metastatic breast cancer;
Keywords: سرطان متاستاتیک سینه; BA; bronchial artery; MBC; metastatic breast cancer; PA; pulmonary artery; PD; progressive disease; RR; response rate; SAP-MS; superabsorbent polymer microspheres;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Progression free survival; Overall survival; Surrogacy; Meta-analysis; ROC curve; Classification tree; Surrogate threshold effect;
Keywords: سرطان متاستاتیک سینه; ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: سرطان متاستاتیک سینه; Cáncer de mama metastásico; Encuesta; MastectomÃa; Reconstrucción mamaria; Metastatic breast cancer; Survey; Mastectomy; Breast reconstruction;
Keywords: سرطان متاستاتیک سینه; Homing peptide; Cabazitaxel; Nanomicelles; Metastatic breast cancer; Necrosis;
Keywords: سرطان متاستاتیک سینه; Bone-only disease; Measurable disease; Endpoints; Metastatic breast cancer; Progression-free survival;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Bone metastases; Biopsy;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Metastatic colorectal cancer; Trastuzumab; Bevacizumab; Anthracycline; Cyclophosphamide; Paclitaxel; Irinotecan; Fluorouracil; Leucovorin;
Keywords: سرطان متاستاتیک سینه; Skeletal-related events; Metastatic breast cancer; Bisphosphonates; Denosumab;
Keywords: سرطان متاستاتیک سینه; Advanced breast cancer; Metastatic breast cancer; Survey; Emotional need; Psychosocial need; Information need;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; HER2; Trastuzumab; Pertuzumab; T-DM1; Lapatinib; Resistance; Management; Novel therapy;
Keywords: سرطان متاستاتیک سینه; Second-line; HER2-negative; Metastatic breast cancer; Monotherapy; Systematic review; Randomised controlled trials
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Central nervous system involvement; Breast cancer subtypes; Locoregional and systemic treatment;
Keywords: سرطان متاستاتیک سینه; High throughput genomics; Next generation sequencing; Comparative genomic hybridization; Metastatic breast cancer;
Keywords: سرطان متاستاتیک سینه; Economic evaluation; Health technology assessment; Trastuzumab; Metastatic breast cancer; Biosimilars;
Keywords: سرطان متاستاتیک سینه; Pancytopenia; Metastatic breast cancer; Doxorubicin; Continuous
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Chemotherapy; Retrospective analysis; Beyond second line; Efficacy;
Keywords: سرطان متاستاتیک سینه; Breast cancer; Metastatic breast cancer; Aggressive breast cancer; Prognostic factors; Biological features; Clinical features;
Keywords: سرطان متاستاتیک سینه; Brain metastases; Inflammatory breast cancer; Metastatic breast cancer; Multimodality therapy; Triple negative breast cancer;
Keywords: سرطان متاستاتیک سینه; CTC; circulating tumour cell; MBC; metastatic breast cancer; CVB; central venous blood; PVB; peripheral venous blood; TCE; tumour cell emboli; ABC; advanced breast cancer; RT-qPCR; reverse transcription quantitative real-time polymerase chain reaction; Ci
Keywords: سرطان متاستاتیک سینه; Chemotherapy; Drug resistance; Metastatic breast cancer; Progression free survival; Response rate;
Keywords: سرطان متاستاتیک سینه; Carbohydrate microarrays; O-glycan cryptic antigens; Circulating tumor cells; Metastatic breast cancer; Tumor immunotyping;
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Treatment response; Positron emission tomography; Bone scan; Computed tomography
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Chemotherapy; Pemetrexed; Anthracycline; Taxane
Keywords: سرطان متاستاتیک سینه; Metastatic breast cancer; Diet; Physical activity; Quality of life; Body mass index
Keywords: سرطان متاستاتیک سینه; BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
Keywords: سرطان متاستاتیک سینه; eribulin; capecitabine; gemcitabine; metastatic breast cancer; triple negative; vinorelbine;
Keywords: سرطان متاستاتیک سینه; First-line treatment; HER2 and HR status; Metastatic breast cancer; Systematic review and meta-analysis; Targeted therapy;